Trials / Completed
CompletedNCT00647491
A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 352 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety, efficacy and pharmacokinetics of three doses of adalimumab in adult Japanese subjects with RA
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | adalimumab | 20 mg sc eow |
| BIOLOGICAL | adalimumab | 40 mg sc eow |
| BIOLOGICAL | adalimumab | 80 mg sc eow |
| BIOLOGICAL | placebo | placebo sc eow |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2005-06-01
- Completion
- 2005-08-01
- First posted
- 2008-03-31
- Last updated
- 2008-03-31
Locations
25 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00647491. Inclusion in this directory is not an endorsement.